Physician profile
Ryan James Green
NPI 1447661533
$652.29
in general payments reported to CMS, 2019-2025
12 companies · $15.75 in 2025
The $15.75 reported for 2025 was less than what a typical Emergency Medicine provider received nationally (typical 2025 total: $57.10).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $108 · 2021: $109 · 2022: $71.18 · 2023: $172 · 2024: $56.51 · 2025: $15.75.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $244.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $244.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $244.67 | 2020-2023 | Xarelto |
| Allergan, INC. | $129.97 | 2019-2020 | |
| Pfizer INC. | $56.03 | 2020-2024 | |
| Abbvie INC. | $50.40 | 2023-2025 | |
| Rare Disease Therapeutics, INC. | $30.11 | 2021-2023 | Anavip |
| E.R. Squibb & Sons, L.L.C. | $28.91 | 2021 | |
| Novartis Pharmaceuticals Corporation | $23.44 | 2024 | |
| Alkermes, INC. | $19.30 | 2023 | Vivitrol |
| Bioxcel Therapeutics, INC. | $18.51 | 2023 | Igalmi |
| Astrazeneca Pharmaceuticals Lp | $17.38 | 2021 | |
| Ucb, INC. | $16.79 | 2019 | |
| Portola Pharmaceuticals, LLC | $16.78 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.